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Improvement of cardiac function in a Patient with Heart 
Failure and LVAD placement with treatment of 
Undiagnosed Acromegaly 
 
Navya Reddy, Xin Zheng, Kevin Codorniz, Antoine E. Sakr, Liset Stoletniy 
Introduction: This case report explores the 
improved cardiac function of treating 
acromegaly in an individual with non-
ischemic dilated cardiomyopathy with a left 
ventricular assist device. The importance of 
this case study underscores that possible 
early treatment of acromegalic 
cardiomyopathy could slow the progression 
of the cardiomyopathy and prevent invasive 
cardiac procedures.  
 
Objectives: The primary objective of this 
review is to underscore a rarely studied 
effect of on acromegalic cardiomyopathy 
and subsequently cardiac function.   
 
Methods: This was a retrospective chart 
review regarding one particular patient case. 
Epic was used to gather clinical data as well 
as hospitalization notes/imaging including 
echo imaging, CT scan. Hormone levels 
were measured from the time of diagnosis to 
eventual improvement of cardiac function. 
Cardiac transthoracic echo was obtained 
prior to and after starting therapy as part of 
regular monitoring.   
 
Case Description: 62-year old male with 
history of non-ischemic cardiomyopathy (EF 
15%)  with placement of an automated 
implantable cardiac defibrillator (AICD), 
pituitary gland tumor, hypothyroidism, and 
remote history of testosterone deficiency, 
presented as a transfer to Loma Linda 
University Medical Center. Prior to his 
transfer he was admitted multiple times for 
persistent heart failure exacerbations in 
Nevada and failed to obtain adequate 
congestive heart failure (CHF) control.  
 
During the course of his hospitalization in 
Loma Linda Hospital (LLH), his volume 
status was optimized and he received 
right/left heart catheterization with no flow-
limiting lesions. It was then decided to 
proceed with placement of a HeartMate II 
Left Ventricular Assist device (LVAD). He 
did well after the placement of the LVAD 
and continued to undergo further workup for 
possible future heart transplant. As a part of 
his ongoing evaluation, Endocrinology was 
contacted for evaluation due to his history of 
a pituitary adenoma. 
 
Upon further discussion, the patient stated 
he was first diagnosed with a pituitary mass 
in October, 2015. He struck his head on the 
pavement while getting out of a car. A CT 
head scan obtained in emergency 
department (ER) showed a pituitary 
incidentaloma. The patient denied having 
visual changes, headaches, weight changes, 
growth changes, decreased libido, or 
disruptions in his sleep at that time. Patient 
stated he was also diagnosed with low 
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testosterone about four years prior and was 
previously on testosterone replacement 
therapy. He was further diagnosed with 
hypothyroidism and has been on continued 
levothyroxine therapy. 
He was subsequently seen by an 
endocrinologist in Nevada for the pituitary 
mass but no other hormonal deficiency or 
excess was diagnosed at that time.  He then 
had an MRI of the brain done that showed a 
2.3x2.4x2.6cm macroadenoma invading the 
cavernous sinus with indention of the 
chiasm and a displaced pituitary stalk.   
 
While undergoing evaluation by LLU 
Endocrinology, his physical exam was 
significant for coarse facial features, large 
hands, mild frontal bossing and some 
widened spacing of his teeth.  This led to 
suspicion for acromegaly.  Further testing 
included a GH hormone suppression test 
which confirmed the diagnosis of 
acromegaly due to a GH secreting pituitary 
macroadenoma. The patient was started 
on lanreotide injection. After several months 
of treatment, his IGF1 levels improved 
significantly, but did not completely return 
to normal.  He was then started on 
cabergoline which then did bring GH levels 
down to normal. On 12/21/17, a repeat TTE 
showed a significant improvement of his left 
ventricular ejection fraction, with increase to 
approximately 40%. This improvement is 
thought to be, at least in part, due to 
normalization of his GH levels. 
 
Discussion: Cardiovascular complications 
are relatively common in patients diagnosed 
with acromegaly. Studies have reported 
early development of endothelial 
dysfunction and structural vascular 
alterations, with subsequent increased risk of 
coronary artery disease (Mosca). Based on 
literature, it is estimated that about 3-10% of 
acromegalic patients developed acromegalic 
cardiomyopathy leading to congestive heart 
failure (Bihan). Acromegalic 
cardiomyopathy is characterized by 
concentric biventricular hypertrophy, 
diastolic dysfunction, and eventually 
progressive impairment of systolic 
performance leading to overt heart failure. 
In these patients, it is believed that chronic 
exposure to high levels of GH and IGF-1 
was the underlying cause, and thus early 
control of GH and IGF-1 excess has been 
crucial in management of such patients. The 
patient we discussed, highlights this point as 
the improvement of LVEF from 15% to 
40% after initiation of Lantreotide and 
Cabergoline further supports these previous 
studies. 
Despite stabilization of heart failure with 
control of GH and IGF-a, heart 
transplantation remains the final solution to 
end stage acromegalic cardiomyopathy. 
There has been anecdotal case reporting of 
heart transplantation in acromegalic patients 
with heart failure (Albat), and a case 
reported on acromegalic cardiomyopathy 
associated malignant arrhythmogenic pattern 
also successfully treated with heart 
transplantation (Doimo). However, due to 
the rarity of the disorder, there has not been 
any case involving an LVAD in the 
treatment of acromegalic cardiomyopathy.  
The use of LVAD in our patient allows time 
for cardiac optimization while attempting to 
control GH and IGF-a, as evidenced by an 
increase in LVEF from 15% to 40%. Such 
improvement allows more time to modify 
other risk factors, such as smoking cessation 
and improve BMI in our patient, therefore 
increasing patient’s chance of survival while 
waiting for heart transplantation.  
Conclusion: Severe heart failure patient 
secondary to non-ischemic cardiomyopathy 
with clinical features of acromegaly or 
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incidental finding of a pituitary adenoma, 
need to be evaluated for acromegalic 
cardiomyopathy. If IGF-a and GH are 
confirmed to be elevated, it is important to 
initiate medication therapy for optimal 
control. In addition, the use of LVAD in 
patients initially not deemed a candidate for 
heart transplantation can provide more time 
for risk factor modification, which may 
eventually give them a second chance to 
receive heart transplantation. 
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